Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy

BACKGROUND: Immunotherapy of cancer is successful but tumor regression often is incomplete and followed by escape. Understanding the mechanisms underlying this acquired resistance will aid the development of more effective treatments. METHODS: We exploited a mouse model where tumor-specific therapeu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Autores principales: Beyranvand Nejad, Elham, Labrie, Camilla, Abdulrahman, Ziena, van Elsas, Marit J, Rademaker, Eva, Kleinovink, Jan Willem, van der Sluis, Tetje C, van Duikeren, Suzanne, Teunisse, Amina F A.S, Jochemsen, Aart G, Oosting, Jan, de Miranda, Noel F C C, Van Hall, Thorbald, Arens, Ramon, van der Burg, Sjoerd H
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467529/
https://ncbi.nlm.nih.gov/pubmed/32873723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001326
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares